Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine and Folic Acid in Schizophrenia
NCT01263080Phase 4Completed
- Sponsor
- Capital Medical University
- Start
- Nov 2010
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of mirtazapine, folic acid in schizophrenia, sponsored by Capital Medical University. Started Nov 2010; status: completed.
02
Drugs
mirtazapinefolic acid
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01263080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01263080.